Aeterna Zentaris Inc.

Aeterna Zentaris Inc.verified

AEZS

Price:

$5.72

Market Cap:

$17.51M

Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests. Its lead product is macimorelin, an orally available peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a for the diagnosis of adult growth hormone deficiency and childhood-onset growth hormone deficiency, as well as oncology indications. The company markets macimorelin under the Macrilen brand name. Aeterna Zentaris Inc. has a license agreement with University Wuerzburg to research, develop, manufacture, and sell a potential COVID-19 vaccine; development, manufacture, and commercializ...[Read more]

Industry

Biotechnology

IPO Date

2000-05-10

Stock Exchange

NASDAQ

Ticker

AEZS

The Enterprise Value as of October 2024 (TTM) for Aeterna Zentaris Inc. (AEZS) is -11767918.00

According to Aeterna Zentaris Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -11767918.00. This represents a change of 671.54% compared to the average of -1525245.66 of the last 4 quarters.

Aeterna Zentaris Inc. (AEZS) Historical Enterprise Value (quarterly & annually)

How has AEZS Enterprise Value performed in the past?

The mean historical Enterprise Value of Aeterna Zentaris Inc. over the last ten years is 77.01M. The current -11767918.00 Enterprise Value has changed -1628.13% with respect to the historical average. Over the past ten years (40 quarters), AEZS's Enterprise Value was at its highest in in the March 2021 quarter at 362.00M. The Enterprise Value was at its lowest in in the March 2024 quarter at -26743591.88.

Quarterly (TTM)
Annual

Average

77.01M

Median

77.47M

Minimum

2.56M

Maximum

179.57M

Aeterna Zentaris Inc. (AEZS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Aeterna Zentaris Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 1.47%

Maximum Annual Enterprise Value = 179.57M

Minimum Annual Increase = -92.43%

Minimum Annual Enterprise Value = 2.56M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20232.56M-77.39%
202211.33M-88.46%
202198.19M114.22%
202045.84M-19.22%
201956.74M-68.40%
2018179.57M33.98%
2017134.03M5.51%
2016127.02M1.47%
20158.07M-92.43%
2014106.72M-10.70%

Aeterna Zentaris Inc. (AEZS) Average Enterprise Value

How has AEZS Enterprise Value performed in the past?

The current Enterprise Value of Aeterna Zentaris Inc. (AEZS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

37.36M

5-year avg

42.93M

10-year avg

77.01M

Aeterna Zentaris Inc. (AEZS) Enterprise Value vs. Peers

How is AEZS’s Enterprise Value compared to its peers?

Aeterna Zentaris Inc.’s Enterprise Value is less than Pulmatrix, Inc. (-5996622.00), less than Onconova Therapeutics, Inc. (4.51M), less than Catalyst Biosciences, Inc. (19.42M), less than Bio-Path Holdings, Inc. (-315014.00), less than Moleculin Biotech, Inc. (-3343901.00), less than Adial Pharmaceuticals, Inc. (3.18M), less than Diffusion Pharmaceuticals Inc. (-1447403.00), less than Tonix Pharmaceuticals Holding Corp. (24.22M), less than Jaguar Health, Inc. (0), less than Acasti Pharma Inc. (27.90M), less than iBio, Inc. (14.78M), less than TransCode Therapeutics, Inc. (14.65M), less than Aditxt, Inc. (5.16M), less than Reviva Pharmaceuticals Holdings, Inc. (12.58M), less than Avenue Therapeutics, Inc. (27.94M), less than null (-1712754.00),

Build a custom stock screener for Aeterna Zentaris Inc. (AEZS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aeterna Zentaris Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Aeterna Zentaris Inc. (AEZS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Aeterna Zentaris Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Aeterna Zentaris Inc.'s Enterprise Value?

What is the highest Enterprise Value for Aeterna Zentaris Inc. (AEZS)?

What is the 3-year average Enterprise Value for Aeterna Zentaris Inc. (AEZS)?

What is the 5-year average Enterprise Value for Aeterna Zentaris Inc. (AEZS)?

How does the current Enterprise Value for Aeterna Zentaris Inc. (AEZS) compare to its historical average?